{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:07:50Z","timestamp":1789168070222,"version":"build-2803163510"},"reference-count":30,"publisher":"Informa UK Limited","issue":"5-6","license":[{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["HIV Clinical Trials"],"published-print":{"date-parts":[[2017,11,2]]},"DOI":"10.1080\/15284336.2017.1379676","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T07:58:20Z","timestamp":1508227100000},"page":"177-188","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["HIV prevention trial design in an era of effective pre-exposure prophylaxis"],"prefix":"10.1080","volume":"18","author":[{"given":"Amy","family":"Cutrell","sequence":"first","affiliation":[{"name":"ViiV Healthcare, Research Triangle Park, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-7480","authenticated-orcid":false,"given":"Deborah","family":"Donnell","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Dunn","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit at UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Glidden","sequence":"additional","affiliation":[{"name":"University of California San Francisco, Epidemiology &amp; Biostatistics Department, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Grobler","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics Unit, Murdoch Childrens Research Institute, Melbourne, Australia"},{"name":"Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Hanscom","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt S.","family":"Stancil","sequence":"additional","affiliation":[{"name":"Parexel International, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Daniel","family":"Meyer","sequence":"additional","affiliation":[{"name":"Pfizer Global Product Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Wang","sequence":"additional","affiliation":[{"name":"Pfizer Global Product Development, Groton, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Cuffe","sequence":"additional","affiliation":[{"name":"ViiV Healthcare, Middlesex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"key":"CIT0001","volume-title":"Truvada [package insert]","year":"2013"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506273"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ778"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402269"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61127-7"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003174"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001160"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506110"},{"key":"CIT0019","volume-title":"Methodological Challenges in Biomedical HIV Prevention Trials","author":"Institute of Medicine","year":"2008"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182986fac"},{"key":"CIT0021","volume-title":"Human immunodeficiency virus-1 infection: developing antiretroviral drugs for treatment: guidance for industry, revision 1","author":"US Food and Drug Administration","year":"2015"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063272"},{"key":"CIT0023","volume-title":"Guide to Clinical Trials","author":"Spilker B","year":"1991"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2004.190.issue-4"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2004.190.issue-4"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2005.191.issue-8"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2005.191.issue-8"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2005.191.issue-8"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2005.191.issue-8"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828607c5"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-0420.2009.01358.x"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1177\/1740774511398923"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3981"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002099"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000218"}],"container-title":["HIV Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15284336.2017.1379676","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15284336.2017.1379676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:48:10Z","timestamp":1556783290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15284336.2017.1379676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":30,"journal-issue":{"issue":"5-6","published-online":{"date-parts":[[2017,12,6]]},"published-print":{"date-parts":[[2017,11,2]]}},"alternative-id":["10.1080\/15284336.2017.1379676"],"URL":"https:\/\/doi.org\/10.1080\/15284336.2017.1379676","relation":{},"ISSN":["1528-4336","1945-5771"],"issn-type":[{"value":"1528-4336","type":"print"},{"value":"1945-5771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}